Tech Center 1600 • Art Units: 1621 1623 1672 1673 1691 1693
This examiner grants 72% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19347574 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS | Non-Final OA | Bexson Biomedical, Inc. |
| 18008684 | IMPROVED DEMINERALIZATION OF FERMENTATION BROTHS AND PURIFICATION OF FINE CHEMICALS SUCH AS OLIGOSACCHARIDES | Final Rejection | BASF SE |
| 18468432 | METHODS FOR ENHANCING CYTOTOXIC CANCER THERAPY THROUGH MODULATION OF PURINE BIOSYNTHESIS PATHWAYS | Final Rejection | Northwestern University |
| 18043254 | RNA STORAGE METHOD | Non-Final OA | KAO CORPORATION |
| 18254488 | POLYROTAXANE HAVING HYDROXY GROUP OR SULFO GROUP | Non-Final OA | NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY |
| 18245743 | BIOMOLECULE EXTRACTION METHOD | Non-Final OA | NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM |
| 17603908 | METHOD AND KIT FOR THE PURIFICATION OF FUNCTIONAL RISC-ASSOCIATED SMALL RNAS | Final Rejection | ETH Zürich |
| 18005943 | PURIFICATION OF SULFONATED DNA | Non-Final OA | Exact Sciences Corporation |
| 18009566 | POLYSACCHARIDE COMPOSITIONS AND THERAPEUTIC GELS | Non-Final OA | The University of Birmingham |
| 18268722 | Pet Food Compositions | Non-Final OA | Hill's Pet Nutrition, Inc. |
| 17986361 | ORTHOESTER COMPOSITIONS FOR AFFINITY PURIFICATION OF OLIGONUCLEOTIDES | Final Rejection | Agilent Technologies, Inc. |
| 18656010 | ANIMAL MODELS, SCREENING METHODS, AND TREATMENT METHODS FOR INTRAOCULAR DISEASES OR DISORDERS | Non-Final OA | SMILEBIOTEK ZHUHAI LIMITED |
| 17950520 | 2'-ALKYL OR 3'- ALKYL MODIFIED RIBOSE DERIVATIVES AND METHODS OF USE | Non-Final OA | Sanegene Bio USA Inc. |
| 17789159 | PHYSICAL MIX HA-COLLAGEN DERMAL FILLERS | Non-Final OA | ALLERGAN, INC. |
| 18001429 | CONJUGATE GROUP AND CONJUGATE | Final Rejection | MEDSHINE DISCOVERY INC. |
| 18512636 | COMPOSITIONS AND METHODS FOR TREATMENT OF MITOCHONDRIAL RESPIRATORY CHAIN DYSFUNCTION AND OTHER MITOCHONDRIAL DISORDERS | Final Rejection | THE CHILDREN'S HOSPITAL OF PHILADELPHIA |
| 18504742 | WOUND DRESSING COMPRISING HYALURONIC ACID-CALCIUM AND POLYLYSINE AND MANUFACTURING METHOD THEREFOR | Non-Final OA | YOUREH CO., LTD. |
| 18278844 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF NEUROINFLAMMATION, COMPRISING ELEUTHEROSIDE B AS ACTIVE INGREDIENT | Non-Final OA | YEP BIO CO. LTD. |
| 18174111 | FUNCTIONALIZED CELLULOSE NANOCRYSTALS STABILIZED SMART PICKERING EMULSION FOR ENHANCED PROBIOTIC DELIVERY | Non-Final OA | UNIVERSITY OF WATERLOO |
| 18041642 | USE OF A HEPARIN COMPOSITION IN THE TREATMENT OF VIRAL LUNG DISEASES, ACUTE AND/OR CHRONIC LUNG DISEASES BY SOFT MIST INHALER OR VIBRATION MESH TECHNOLOGY NEBULIZER THROUGH INHALATION ROUTE | Non-Final OA | ISTANBUL UNIVERSITESI REKTORLUGU |
| 18020944 | FISH SWIM BLADDER-DERIVED HEPARIN-LIKE MUCOPOLYSACCHARIDE AND METHODS OF MAKING AND USING THE SAME | Non-Final OA | SHENZHEN INSTITUTE OF GUANGDONG OCEAN UNIVERSITY |
| 18007982 | CANNABINOID-HYALURONIC ACID BIOCONJUGATES | Non-Final OA | LONDON PHARMACEUTICALS AND RESEARCH CORPORATION |
| 17999910 | COMPOUNDS FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF THROMBI | Non-Final OA | CARDIOVASCULAR LAB S.P.A |
| 17924565 | COMPATIBLE SOLUTES FOR PREVENTING OR TREATING SARS-COV-2 INFECTIONS | Non-Final OA | bitop AG |
| 17916382 | COMPOSITION AND METHOD FOR PRODUCING A COMPOSITION | Final Rejection | BIOPRONEO B.V. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy